What Carebot does

Carebot s.r.o. is a Czech private company (founded 2021, headquartered in Prague) that develops a portfolio of CE-marked, EU MDR Class IIa certified AI software modules for medical imaging analysis. Its products — AI CXR (chest X-ray), AI Bones (musculoskeletal/fracture detection with Bone Age and Cobb angle sub-modules), AI Mammography, AI Head CT, and AI Lungs CT — use proprietary deep learning models to detect, localize, and quantify pathological findings and automatically generate structured text reports. The software integrates directly into existing hospital PACS, RIS, and HIS systems via DICOMweb API and encrypted HTTPS, with no required changes to radiologist workflows, and produces reports in 20+ languages. The company was acquired by Pilulka Lab in December 2021 and reports operating in hundreds of hospitals across more than ten countries spanning Central and Eastern Europe, Germany, the Middle East (UAE), and Vietnam.

The business is structured as a B2B enterprise software company selling primarily through direct enterprise field sales, with a sales-led go-to-market supported by clinical evidence and conference presence (e.g., European Congress of Radiology). Revenue is generated from subscription/recurring SaaS licensing of its AI modules, supplemented by one-time license fees for OEM integrations and professional services for deployment. The go-to-market combines a direct sales team covering the Czech Republic and international markets, a partner network within the "Horizon by Carebot" extended portfolio (e.g., Hera-MI for mammography, BrainScan for head CT), and strategic collaborations such as a flagship global partnership with Bristol Myers Squibb for early lung cancer detection that has analyzed 140,000+ chest X-rays since 2025. In January 2026 the company announced its largest funding round to date, targeting 8-10 million EUR to accelerate global expansion, build commercial teams, and fund new product development including a planned radiology-specific LLM reporting assistant.

Name

Carebot

Legal name

Carebot s.r.o.

Website

https://carebot.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

11–50 employees

Short description

Carebot is a Czech AI medical imaging company that sells EU MDR Class IIa certified deep learning software for chest X-ray, musculoskeletal, mammography, and CT analysis, integrated into hospital PACS systems, serving hundreds of hospitals across more than ten countries.

Ownership category

akta.pro rank

Product category

AI Radiology Software

NAICS

Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451), Diagnostic Imaging Centers (621512)

SIC

Services-Prepackaged Software (7372), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Radiology AI, CAD & Advanced Visualization Software (HLAHABAJ)

akta.pro secondary industries

SaMD – Imaging & Signal Analysis (AI/ML) (HLACANAG), Medical Imaging AI (HDAAAEAH)

Keywords

• AI medical imaging
• Radiology software
• Diagnostic AI solutions
• Clinical decision support
• Medical device software

Headquarters

HQ city

Prague

HQ country

Czechia

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. AI Software Licensing: SaaS-based licensing model for AI medical imaging software modules. Software deployed in hospitals with subscription or license fee structure including training and support.
2. Direct Software Sales: Direct sales of software to healthcare companies for integration into their hardware devices. Part of Carebot AI Prostate Pathology business model.
3. Enterprise Deployment Services: Implementation services including consultation, technical preparation, installation, training, pilot deployment, and ongoing support as part of the deployment process.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels6 records

Core offering

Carebot develops and sells CE-marked, EU MDR Class IIa-certified AI software that automatically analyzes X-ray, CT, and mammography images to highlight suspicious findings, generate structured reports, and prioritize urgent cases. The modular product line (Carebot AI CXR, AI Bones, AI Mammography, AI Head CT, AI Lungs CT, plus Bone Age and Measurements add-ons) integrates directly into hospital PACS/RIS/HIS environments and is sold to hospitals and radiology departments on a SaaS licensing basis.

Product overview

Carebot is a modular AI radiology platform offering a portfolio of certified AI solutions for medical imaging analysis. The core products include Carebot AI CXR for chest X-ray analysis, Carebot AI Bones for fracture detection on musculoskeletal X-rays, AI Mammography for breast imaging screening, AI Head CT for brain scan analysis, and AI Lungs CT for pulmonary nodule detection. The platform also includes specialized modules such as Bone Age (estimating skeletal maturity from hand X-rays) and Measurements (Cobb angle measurement for scoliosis assessment). All solutions integrate directly into existing PACS environments, automatically generating structured text reports that are delivered to hospital information systems. The Horizon by Carebot extension provides comprehensive tools for clinical use from emergency care to oncological screening.

Differentiator

Problem solved

Functional benefit

Brands

• Horizon by Carebot: Extended portfolio bringing together solutions from Carebot and close partners, including BrainScan CT for head CT analysis and Breast-SlimView for mammography.
• Carebot AI CXR
• Carebot AI Bones
• Carebot AI MMG

Products and services

• Carebot AI CXR AI-powered chest X-ray analysis system for radiologists that highlights suspicious findings (pulmonary lesion, consolidation, pneumothorax, pleural effusion, cardiomegaly, atelectasis, subcutaneous emphysema) and external medical devices, supporting early lung cancer detection with results in 15 seconds and sensitivity up to 95%.
• Carebot AI Bones AI solution for detecting fractures and dislocations on musculoskeletal X-ray images across multiple skeletal regions, including typical pediatric fractures, with validated 91.5% sensitivity and 92.3% specificity and risk prioritization for emergency and outpatient settings.
• AI Mammography
• AI Head CT AI brain CT triage solution for emergency departments that detects 30 key findings including vascular pathologies, traumatic injuries, vascular malformations, and tumors, reducing time to treatment by approximately 69 minutes for stroke, 66 minutes for intracerebral hemorrhage, and 33 minutes for intracranial injury.
• AI Lungs CT AI solution for lung CT analysis that detects pulmonary nodules and abnormalities, provides malignancy risk estimation, localizes nodules within the lungs, quantifies imaging features, and performs longitudinal nodule tracking, with results within 3 minutes and up to 33% reading-time reduction.
• Bone Age Add-on functionality of Carebot AI Bones that estimates biological bone age from hand and wrist X-ray images using the Greulich-Pyle atlas standard, providing automated, objective, and reproducible bone age assessment to support pediatric growth disorder diagnosis and skeletal development monitoring.
• Measurements Add-on functionality of Carebot AI Bones for rapid, objective quantitative assessment of spinal deformities, including automatic Cobb angle measurement, spinal curvature analysis, and severity assessment for scoliosis diagnosis and monitoring.

Quantifiable outcome

• Sensitivity increased from 86.26% to 94.56% with AI assistance for fracture detection (+8.30 percentage points)
• +6 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability7 records

Feature7 records

Partnerships

Five partnerships are on record, tiered strategic, flagship, core and extended.

• Bach Mai HospitalstrategicStrategic or Co-development Partner · 31 March 2026Clinical collaboration with Bach Mai Hospital in Hanoi, Vietnam - one of the largest medical institutions in the country. Memorandum of Cooperation signed for implementation and use of Carebot's AI solutions in clinical practice. Part of Carebot's expansion into Asia and smart hospital transformation initiatives.
• Bristol Myers SquibbflagshipStrategic or Co-development Partner · 1 January 2025Global collaboration for early cancer detection using AI. Since 2025, the partnership has analyzed nearly 140,000 chest X-rays, referred 1,077 patients for further diagnostic workup, and achieved 67 first-time lung cancer diagnoses and nearly 300 malignant findings overall. Project evaluated as one of top three worldwide.
• Microsoft Ireland Operations LimitedcoreTechnology or IntegrationSub-processor providing Microsoft Azure cloud service used by Carebot software. Only processes personal data in providing the Azure cloud service. Data processing documented in GDPR-compliant data processing agreement.
• Hera-MIextendedTechnology or IntegrationPartner within Horizon by Carebot portfolio providing Breast-SlimView, a patented clinical decision support system for 2D and 3D mammography. Carebot AI MMG incorporates Hera-MI technology.
• BrainScanextendedTechnology or IntegrationPartner within Horizon by Carebot portfolio providing BrainScan CT for AI Head CT analysis. BrainScan CT is developed and owned by BrainScan, integrated into Carebot's extended portfolio.

Scale indicators7 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• Lunit: South Korea-based medical AI company with FDA-cleared chest X-ray triage (LUNIT INSIGHT CXR) and mammography (Lunit INSIGHT MMG) solutions. Direct competitor in the same modality mix as Carebot, including mammography AI.
• Annalise.ai: Australia-based comprehensive radiology AI platform covering 130+ findings across chest X-ray, CT, and other modalities. Direct peer in the multi-modality, hospital PACS-integrated AI radiology space with similar CE-marking strategy.
• Aidoc: Israel/US-based clinical AI platform with FDA-cleared modules for head CT, chest CT, and triage, integrated with PACS workflows. Direct competitor in hospital radiology AI with deeper US footprint and broader scan-coverage portfolio.
• Viz.ai: US-based AI platform specializing in stroke and neurovascular triage via head CT analysis, with FDA clearance and broad US hospital footprint. Overlaps with Carebot's AI Head CT module, particularly on time-critical emergency department use cases.
• Oxipit: Lithuania-based CE-marked chest X-ray AI vendor with strong European hospital presence and MDR pathway. Direct peer geographically (EU/CEE) and product-wise, competing for the same radiology AI budgets.
• Qure.ai: India-based radiology AI company with FDA- and CE-cleared products spanning chest X-ray, head CT, and lung nodule detection. Highly comparable to Carebot on product modality mix, hospital enterprise sales motion, and emerging-market go-to-market focus.
• Gleamer: France-based AI radiology company with a CE-marked bone fracture detection product (BoneView) that directly competes with Carebot AI Bones, plus chest X-ray and mammography modules. Closest European direct peer in fracture and trauma imaging AI.

Broad incumbents

• DeepHealth (RadNet): US-based subsidiary of RadNet (a major diagnostic imaging operator) providing AI-powered radiology interpretation and screening workflows, including mammography. Broad incumbent with embedded imaging-center footprint and FDA-cleared products overlapping with Carebot's mammography and chest imaging modules.

Emerging players

• Infervision: China-based medical imaging AI company with CT and X-ray products deployed in Asian hospital systems. Comparable on technology and modality mix, with stronger Asia footprint but a less European/governmental go-to-market posture.

Others

• Hera-MI: France-based breast imaging AI vendor whose Breast-SlimView product is integrated into Carebot's "Horizon by Carebot" portfolio. They are a partner of Carebot but also a partial competitor in mammography AI; comparable on modality and certification posture.

Market position

Strengths5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/carebot-cz

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds6 records

Investors10 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Carebot